Triple agent immunosuppressive therapy in Vogt-Koyanagi-Harada syndrome

Mamta Agarwal, Sudha K. Ganesh, Jyotirmay Biswas

Producción científica: Review articlerevisión exhaustiva

44 Citas (Scopus)

Resumen

Purpose: To describe the role of triple agent immunosuppression in severe recalcitrant cases of Vogt-Koyanagi-Harada syndrome. Materials and methods: Retrospective chart review of five cases of Vogt-Koyanagi-Harada syndrome. Results: All cases were treated with oral prednisolone, azathioprine, and cyclosporine in combination, and rapid remission was observed in all patients. The synergistic effect of the triple agent immunosuppressives helped in preventing recurrences. Prolonged treatment with steroid sparing immunosuppressives in severe and recalcitrant cases of Vogt-Koyanagi-Harada syndrome maintained disease remission. Conclusion: Severe cases of Vogt-Koyanagi-Harada syndrome can be treated with early use of high-dose triple agent immunosuppressives.

Idioma originalEnglish (US)
Páginas (desde-hasta)333-339
Número de páginas7
PublicaciónOcular Immunology and Inflammation
Volumen14
N.º6
DOI
EstadoPublished - sept 1 2006
Publicado de forma externa

ASJC Scopus subject areas

  • Immunology and Allergy
  • Ophthalmology

Huella

Profundice en los temas de investigación de 'Triple agent immunosuppressive therapy in Vogt-Koyanagi-Harada syndrome'. En conjunto forman una huella única.

Citar esto